| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2023 | Apr 4, 2023 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 22.5 | -16,278 | -12.27% | ✗ | $111.3K |
| Jan 10, 2023 | Jan 12, 2023 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 22.5 | -7,204 | -7.31% | ✗ | $72.4K |
| Jan 4, 2023 | Jan 6, 2023 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 22.5 | -5,437 | -5.23% | ✗ | $53.7K |
| Apr 1, 2022 | Apr 5, 2022 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 46.3 | -3,458 | -3.22% | ✗ | $44.4K |
| Jan 10, 2022 | Jan 12, 2022 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 22.5 | -7,733 | -6.72% | ✗ | $110.8K |
| Mar 9, 2021 | Mar 11, 2021 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 17.5 | -114,240 | -68.15% | ✗ | $1.9M |
| Jan 10, 2021 | Jan 12, 2021 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 22.5 | -4,080 | -10.74% | ✗ | $74.2K |
| Dec 9, 2020 | Dec 11, 2020 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 17.5 | -67,138 | -47.79% | ✗ | $1.2M |
| Jan 10, 2020 | Jan 14, 2020 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 95.0 | +36,673 | 187.95% | ✗ | $61.6K |
| Jan 11, 2019 | Jan 15, 2019 | Coherus Oncology, Inc. | Chief Scientific Officer | Sell | 95.0 | +9,646 | 123.22% | ✗ | $73.2K |